Showing results (151-160 of 5,924) with videos related to

Sort By:
Pageof 593
The Prostate|March 8, 2007
Frequency and number of neuroendocrine tumor cells in prostate cancer: no difference between radical prostatectomy specimens from patients with and without neoadjuvant hormonal therapyShinichiro Shimizu, Jiro Kumagai, Yoshinobu Eishi, et al.
The Prostate|March 8, 2007
Sonic and desert hedgehog signaling in human fetal prostate developmentGuodong Zhu, Haiyen E Zhau, Hui He, et al.
The Prostate|March 8, 2007
Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expressionHiroaki Fuse, Shigeru Korenaga, Matomo Sakari, et al.
The Prostate|March 8, 2007
Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse modelChia-Ling Hsieh, Zhihui Xie, Jie Yu, et al.
The Prostate|March 8, 2007
IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor ratsN V Rajeshkumar, George Matwyshyn, Anil Gulati
The Prostate|January 1, 1992
Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivoS Eklöv, S Nilsson, A Larson, et al.
The Prostate|January 1, 1990
Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesiclesG Aumüller, J Seitz, H Lilja, et al.
The Prostate|September 26, 2006
Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328Hannes Steiner, Ilaria T Cavarretta, Patrizia L Moser, et al.
The Prostate|September 26, 2006
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgensVanessa C Thompson, Tanis G W Morris, Dawn R Cochrane, et al.
The Prostate|December 29, 2006
TGFBR3 loss and consequences in prostate cancerNima Sharifi, Elaine M Hurt, Brian T Kawasaki, et al.
Pageof 593